To prevent patients from avoiding care when they cannot afford it, providers should collaborate with them to eliminate unnecessary testing, reduce the frequency of follow-up visits where possible, and make manageable payment plans.
Deciding whether to recommend Avastin or Lucentis raises ethical issues. Should the public health consequences of using a far more expensive drug trump what the doctor thinks is best for the individual patient?
The guidelines for patients’ eligibility for bariatric surgery have not changed since 1991, although recent data suggest there may be indications for broadening application of the surgery.